Kinevant

Details:

Details about Kinevant

Kinevant Sciences (kine-a-vant) is developing new therapies for rare inflammatory and autoimmune diseases, initially focusing on sarcoidosis with an anti-GM-CSF monoclonal antibody (namilumab).

[email protected]

Employees:

Employees at Kinevant

William Gerhart

Chief Executive Officer at Kinevant

Simon Lowry

CMO at Kinevant

Brendan Rousseau

Associate Director of Finance at Kinevant

Lisa Sherman

Head Of Clinical Operations at Kinevant

Alejandro Bohorquez

Associate at Kinevant

Tuan Nguyen

Chief Financial Officer at Kinevant

Rayne Rodgers

Senior Director and Head of Patient Advocacy at Kinevant